Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Autoimmune Neurological Disorders and Treatments, Peripheral Neuropathies and Disorders, Genetic Neurodegenerative Diseases, and Cancer Immunotherapy and Biomarkers.
Brain atrophy patterns in anti-IgLON5 disease
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease
Predictors and Clinical Characteristics of Relapses in LGI1-Antibody Encephalitis
HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis
Novel risk loci in LGI1-antibody encephalitis: genome-wide association study discovery and validation cohorts
Dysautonomia in anti-Hu paraneoplastic neurological syndromes
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity
Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis
Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis
Different Genetic Signatures of Small‐Cell Lung Cancer Characterize <scp>Anti‐GABA<sub>B</sub>R</scp> and <scp>Anti‐Hu</scp> Paraneoplastic Neurological Syndromes
Anti-AGO1 Antibodies Identify a Subset of Autoimmune Sensory Neuronopathy
Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA)
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors
Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis
Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses
Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies
Cerebellar Ataxia With Anti-DNER Antibodies
SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques
Paraneoplastic encephalitis: clinically based approach on diagnosis and management
Immunomodulation in the acute phase of autoimmune encephalitis
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
Neurologic Adverse Events of Immune Checkpoint Inhibitors
Glial Fibrillary Acidic Protein Autoimmunity
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis
Role of LGI1 protein in synaptic transmission: From physiology to pathology
Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis
Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis
Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis